Cargando…
Inhibition of neutral sphingomyelinase 2 impairs HIV-1 envelope formation and substantially delays or eliminates viral rebound
Although HIV-1 Gag is known to drive viral assembly and budding, the precise mechanisms by which the lipid composition of the plasma membrane is remodeled during assembly are incompletely understood. Here, we provide evidence that the sphingomyelin hydrolase neutral sphingomyelinase 2 (nSMase2) inte...
Autores principales: | Yoo, Seung-Wan, Waheed, Abdul A., Deme, Pragney, Tohumeken, Sehmus, Rais, Rana, Smith, Matthew D., DeMarino, Catherine, Calabresi, Peter A., Kashanchi, Fatah, Freed, Eric O., Slusher, Barbara S., Haughey, Norman J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334757/ https://www.ncbi.nlm.nih.gov/pubmed/37406092 http://dx.doi.org/10.1073/pnas.2219543120 |
Ejemplares similares
-
Presence of Viral microRNA in Extracellular Environments
por: DeMarino, Catherine, et al.
Publicado: (2017) -
Inhibition of neutral sphingomyelinase 2 promotes remyelination
por: Yoo, Seung-Wan, et al.
Publicado: (2020) -
Glutamine antagonist JHU083 improves psychosocial behavior and sleep deficits in EcoHIV-infected mice
por: Bell, Benjamin J., et al.
Publicado: (2022) -
DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation
por: Rojas, Camilo, et al.
Publicado: (2018) -
Association of Plasma Eicosanoid Levels With Immune, Viral, and Cognitive Outcomes in People With HIV
por: Deme, Pragney, et al.
Publicado: (2022)